Xavier Jouven
Prof Xavier Jouven is an expert in Cardiology at Hôpital Européen Georges-Pompidou (France). As of October 2026, ScienceLeadR ranks Xavier Jouven in the top 1% of experts worldwide for Heart Arrest, Death, Sudden and Epidemiologic Studies. Xavier Jouven has authored 651 publications, the most recent in 2026, and is an investigator in 16 clinical trials, 1 of them ongoing. SLR score: 2,746 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Public Health - Critical Care - Biostatistics
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1999 - 2026
Number : 651
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Atenolol or Bisoprolol after Myocardial Infarction without Recorded Heart Failure. PMID 42770784 — mortality, myocardial infarction, heart failure, heart, atenolol, bisoprolol, therapeutics | NEJM Evid | 2026 | 1 |
| Subcutaneous Implantable Cardioverter-Defibrillator Therapy in Women. PMID 42554569 — mortality, epidemiology, cardiovascular diseases, cohort studies, heart arrest, sex, death, sudden, cardiac, therapeutics, defibrillators, implantable, defibrillators | JACC Clin Electrophysiol | 2026 | 0 |
| Male predominance in sports sudden cardiac arrest: a behavioural driver of risk? PMID 42357808 — heart arrest, sports | Europace | 2026 | 0 |
| SGLT2 Inhibition as a Novel Therapeutic Strategy in Rheumatic Heart Disease. PMID 42233563 — heart valve diseases, epidemiology, heart diseases, mitral valve, heart, rheumatic heart disease, therapeutics | JACC Asia | 2026 | 0 |
| A Prediction Model for Risk of Death in Kidney Transplant Recipients. PMID 42024384 — mortality, kidney, transplants, prognosis | JAMA Netw Open | 2026 | 0 |
Clinical Studies 16
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 3
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Risk Markers of Arterial Aging The Paris Prospective Study III 2 NCT06079424 — baroreflex, aging, cardiovascular diseases, risk factors, prospective studies | N/A | Recruiting | 2025 |
LeadR Networks
Main global connection map